Table 1. Demographic and disease characteristics of the CHB patients (n=48).
| Characteristic | N (SD or %) |
|---|---|
| Age, mean (SD), years | 36 (±9) |
| Sex, male | 37 (77%) |
| ALT, mean (SD), U/L | 86 (±138) |
| HBeAg(+) | 17 (35%) |
| HBV DNA, mean (SD), log10 IU/mL | 3.67 (±3.26) |
| HBV DNA >6 log10 IU/mL | 15 (31%) |
| 6 log10 IU/mL > HBV DNA >3 log10 IU/mL | 11 (23%) |
| 3 log10 IU/mL > HBV DNA >20 IU/mL | 6 (13%) |
| HBV DNA, undetected | 16 (33%) |
| HBsAg titre, mean (SD), log10 IU/mL | 3.21 (±1.23) |
| HBsAg ≤100 IU/mL | 6 (13%) |
| 100 IU/mL < HBsAg ≤1,000 IU/mL | 12 (25%) |
| 1,000 IU/mL < HBsAg ≤10,000 IU/mL | 17 (35%) |
| 10,000 IU/mL < HBsAg | 13 (27%) |
| miR-3, mean (SD), log10 copies/mL | 6.41 (±3.55) |
| pgRNA, mean (SD), log10 copies/mL | 3.62 (±2.60) |
CHB, chronic hepatitis B; SD, standard deviation; ALT, alanine aminotransferase; HBeAg, hepatitis B e antigen; HBV, hepatitis B virus; HBsAg, hepatitis B surface antigen; pgRNA, pregenomic RNA.